Clot removal vs clot-busting drugs for severe lung clots
Part of Blood & lymphatic, Heart & circulation clinical trials.
This study compares two ways to treat a large blood clot in the lungs that is causing life-threatening symptoms. One method uses a device to remove the clot, the other uses medicine to dissolve it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a confirmed large blood clot in your lung causing very low blood pressure or needing a machine to help your heart restart.
- You have a fast-available treatment center that can start the procedure within an hour.
- You do not have other major reasons for your low blood pressure, like severe lung disease or heart failure.
- You have not recently had a stroke, major surgery, or serious bleeding.
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a standard procedure using a catheter to deliver clot-dissolving medicine directly into the lung artery works well for people with a serious but not immediately life-threatening blood clot in the lungs (pulmonary embolism). It aims to improve heart function and reduce long-term complications.
This study looks at how well a catheter (a thin tube) works to treat a serious type of blood clot in the lungs. It is for people who have a large clot that is causing problems like fast heart rate or low blood pressure.
This study tests a new catheter-based device that delivers clot-dissolving medicine directly to the blood clot in the lungs for people with a moderate-risk pulmonary embolism. The goal is to improve blood flow to the lungs and relieve symptoms with a lower dose of medication than standard care.
This trial tests two ways to treat a serious blood clot in the lungs: removing the clot with a small tube (catheter) alone, or combining that with a low dose of clot-dissolving medicine. The goal is to find a safer and effective treatment for people who can't have standard clot-busting treatment.
This trial tests a procedure to remove blood clots from the lungs using a tube (catheter) to open blocked vessels. It may help people with a sudden pulmonary embolism who are stable enough to undergo the procedure.
This study looks at how well different treatments work for a blood clot in the lung (pulmonary embolism). It includes people who are getting or have already gotten a clot-dissolving medicine or a catheter procedure to remove the clot.
Hear when a new Pulmonary Embolism Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.